<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01065584</url>
  </required_header>
  <id_info>
    <org_study_id>OSCITT10</org_study_id>
    <nct_id>NCT01065584</nct_id>
  </id_info>
  <brief_title>An Observational Study to Assess the Effect of Calcineurin Inhibitors on Markers of Transplant Tolerance</brief_title>
  <acronym>OSCITT</acronym>
  <official_title>An Observational Study to Assess the Effect of Calcineurin Inhibitors on Markers of Transplant Tolerance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Goettingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Goettingen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In experimental and clinical settings it has been shown that transplant tolerance is
      possible. It has been suggested that regulatory T cells play a beneficial role in the
      establishment of tolerance. Calcineurin inhibitors may inhibit development of regulatory T
      cells. However, the influence of calcineurin inhibitors on markers of transplant tolerance
      has not been studied in patients undergoing liver transplantation. Currently the
      investigators conduct a study to evaluate the safety and efficacy of a calcineurin inhibitor
      free immunosuppression in patients undergoing liver transplantation. In this study
      measurements of immune function and CD4+CD25high-Foxp3+-Il2/CD8+ status will also be
      performed. In parallel these measurements should be compared to a group of patients
      undergoing standard immunosuppression including calcineurin inhibitors.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2010</start_date>
  <completion_date type="Anticipated">April 2012</completion_date>
  <primary_completion_date type="Anticipated">February 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">58</enrollment>
  <condition>Liver Transplantation</condition>
  <arm_group>
    <arm_group_label>Standard immunosuppression</arm_group_label>
    <description>Patients receiving standard immunosuppression after liver transplantation including calcineurininhibitors</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Immunosuppression without calcineurininhibitors</arm_group_label>
    <description>Patients receiving immunosuppression after liver transplantation not based on calcineurininhibitors</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood cells for fluorescence activated cell sorting and leukocytes for ImmuKnow/Cylex assay
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing liver transplantation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing primary liver transplantation

          -  Patients of age 18 years and older

          -  Female patients of childbearing potential willing to perform a highly effective
             contraception during the study and 12 weeks after conclusion of study participation

        Exclusion Criteria:

          -  Multiple organ graft recipients

          -  Patients receiving ABO incompatible grafts

          -  Patients with positive cross match

          -  Pregnancy

          -  Patients with a psychological, familial, sociologic or geographic condition
             potentially hampering compliance with the study protocol and follow-up schedule

          -  Patients under guardianship (e.g. individuals who are not able to freely give their
             informed consent)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aiman Obed, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>University Medical Center Goettingen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Armin Goralczyk, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Goettingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aiman Obed, Prof. Dr.</last_name>
    <phone>+49 551 3912296</phone>
    <email>aobed@chirurgie-goettingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Armin D Goralczyk, Dr.</last_name>
    <phone>+49 551 3914638</phone>
    <email>agoralczyk@med.uni-goettingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Medical Center Goettingen</name>
      <address>
        <city>Goettingen</city>
        <state>Niedersachsen</state>
        <zip>37099</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Armin D Goralczyk, Dr.</last_name>
      <phone>+49 551 3914638</phone>
      <email>agoralczyk@med.uni-goettingen.de</email>
    </contact>
    <contact_backup>
      <last_name>Aiman Obed, Prof. Dr.</last_name>
      <phone>+49 551 39 12296</phone>
      <email>aobed@chirurgie-goettingen.de</email>
    </contact_backup>
    <investigator>
      <last_name>Armin Goralczyk, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aiman Obed, Prof. Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2010</study_first_submitted>
  <study_first_submitted_qc>February 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2010</study_first_posted>
  <last_update_submitted>September 14, 2011</last_update_submitted>
  <last_update_submitted_qc>September 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Goettingen</investigator_affiliation>
    <investigator_full_name>Armin Goralczyk</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>liver transplantation</keyword>
  <keyword>Patients undergoing liver transplantation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcineurin Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

